106 related articles for article (PubMed ID: 8795045)
1. Molecular recognition of the Lewis Y antigen by monoclonal antibodies.
Blaszczyk-Thurin M; Murali R; Westerink MA; Steplewski Z; Co MS; Kieber-Emmons T
Protein Eng; 1996 May; 9(5):447-59. PubMed ID: 8795045
[TBL] [Abstract][Full Text] [Related]
2. Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody.
Murali R; Kieber-Emmons T
J Mol Recognit; 1997; 10(6):269-76. PubMed ID: 9770651
[TBL] [Abstract][Full Text] [Related]
3. The x-ray structure of an anti-tumour antibody in complex with antigen.
Jeffrey PD; Bajorath J; Chang CY; Yelton D; Hellström I; Hellström KE; Sheriff S
Nat Struct Biol; 1995 Jun; 2(6):466-71. PubMed ID: 7664109
[TBL] [Abstract][Full Text] [Related]
4. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens.
Ramsland PA; Farrugia W; Bradford TM; Mark Hogarth P; Scott AM
J Mol Biol; 2004 Jul; 340(4):809-18. PubMed ID: 15223322
[TBL] [Abstract][Full Text] [Related]
5. A molecular basis for functional peptide mimicry of a carbohydrate antigen.
Luo P; Canziani G; Cunto-Amesty G; Kieber-Emmons T
J Biol Chem; 2000 May; 275(21):16146-54. PubMed ID: 10748116
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes.
Garrigues J; Anderson J; Hellström KE; Hellström I
J Cell Biol; 1994 Apr; 125(1):129-42. PubMed ID: 7511141
[TBL] [Abstract][Full Text] [Related]
7. Crystallization and preliminary X-ray analysis of the monoclonal anti-tumor antibody BR96 and its complex with the Lewis Y determinant.
Chang CY; Jeffrey PD; Bajorath J; Hellström I; Hellström KE; Sheriff S
J Mol Biol; 1994 Jan; 235(1):372-6. PubMed ID: 8289260
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical studies on the interaction between synthetic glycoconjugates and alpha-L-fucosyl binding lectins.
Petryniak J; Goldstein IJ
Biochemistry; 1986 May; 25(10):2829-38. PubMed ID: 3718924
[TBL] [Abstract][Full Text] [Related]
9. Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens.
Luo P; Agadjanyan M; Qiu J; Westerink MA; Steplewski Z; Kieber-Emmons T
Mol Immunol; 1998 Sep; 35(13):865-79. PubMed ID: 9839555
[TBL] [Abstract][Full Text] [Related]
10. Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants.
Kitamura K; Stockert E; Garin-Chesa P; Welt S; Lloyd KO; Armour KL; Wallace TP; Harris WJ; Carr FJ; Old LJ
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12957-61. PubMed ID: 7809154
[TBL] [Abstract][Full Text] [Related]
11. Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells.
Brodzik R; Glogowska M; Bandurska K; Okulicz M; Deka D; Ko K; van der Linden J; Leusen JH; Pogrebnyak N; Golovkin M; Steplewski Z; Koprowski H
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8804-9. PubMed ID: 16720700
[TBL] [Abstract][Full Text] [Related]
12. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
[TBL] [Abstract][Full Text] [Related]
13. Novel carbohydrate specificity of monoclonal antibody 91.9H prepared against human colonic sulfomucin: recognition of sulfo-Lewis(a) structure.
Tsuiji H; Hong JC; Kim YS; Ikehara Y; Narimatsu H; Irimura T
Biochem Biophys Res Commun; 1998 Dec; 253(2):374-81. PubMed ID: 9878545
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional model of the BR96 monoclonal antibody variable fragment.
Bajorath J
Bioconjug Chem; 1994; 5(3):213-9. PubMed ID: 7522581
[TBL] [Abstract][Full Text] [Related]
15. Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering.
Schuster M; Umana P; Ferrara C; Brünker P; Gerdes C; Waxenecker G; Wiederkum S; Schwager C; Loibner H; Himmler G; Mudde GC
Cancer Res; 2005 Sep; 65(17):7934-41. PubMed ID: 16140965
[TBL] [Abstract][Full Text] [Related]
16. Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys.
Co MS; Baker J; Bednarik K; Janzek E; Neruda W; Mayer P; Plot R; Stumper B; Vasquez M; Queen C; Loibner H
Cancer Res; 1996 Mar; 56(5):1118-25. PubMed ID: 8640770
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with lewis Y-expressing epithelial tumors.
Saleh MN; Sugarman S; Murray J; Ostroff JB; Healey D; Jones D; Daniel CR; LeBherz D; Brewer H; Onetto N; LoBuglio AF
J Clin Oncol; 2000 Jun; 18(11):2282-92. PubMed ID: 10829049
[TBL] [Abstract][Full Text] [Related]
18. The effect of substituting key hydroxyl groups by amino groups on the binding of the Lewis b tetrasaccharide by a lectin and a monoclonal antibody.
Lemieux RU; Szweda R; Paszkiewicz-Hnatiw E; Spohr U
Carbohydr Res; 1990 Sep; 205():C12-8. PubMed ID: 2276127
[No Abstract] [Full Text] [Related]
19. A monoclonal antibody to Lewis Y/Lewis b revealing mimicry of the histone H1 to carbohydrate structures.
Christensen PA; Danielczyk A; Ravn P; Stahn R; Karsten U; Goletz S
Scand J Immunol; 2007 Apr; 65(4):362-7. PubMed ID: 17386027
[TBL] [Abstract][Full Text] [Related]
20. A Lewis(y) epitope mimicking peptide induces anti-Lewis(y) immune responses in rabbits and mice.
Lou Q; Pastan I
J Pept Res; 1999 Mar; 53(3):252-60. PubMed ID: 10231713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
